Granite Islands Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$829K Buy
14,380
+1,045
+8% +$60K 0.61% 51
2026
Q1
$809K Buy
13,335
+8,335
+167% +$486K 0.75% 45
2025
Q4
$270K Buy
+5,000
New +$241K 0.25% 72

Other funds holding BMY

Granite Islands Private Wealth's BMY Position: Q2 2026 in Review

Granite Islands Private Wealth increased its Bristol-Myers Squibb (BMY) stake by 7.8% in Q2 2026, buying an estimated $60K and bringing the position to 14,380 shares worth $829K. The position accounts for 0.61% of the portfolio, ranked #51.

Granite Islands Private Wealth first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Granite Islands Private Wealth held 14,380 shares of Bristol-Myers Squibb worth $829K as of Q2 2026.
  • Granite Islands Private Wealth bought 1,045 Bristol-Myers Squibb shares in Q2 2026, an estimated $60K.
  • Bristol-Myers Squibb made up 0.61% of Granite Islands Private Wealth's portfolio in Q2 2026, its #51 holding.
  • Granite Islands Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Granite Islands Private Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.